Showing results (651-660 of 678) with videos related to

Sort By:
Pageof 68
Plos Neglected Tropical Diseases|June 15, 2026
Comparison of a recombinant endonuclease III protein and its synthetic peptides in ELISA for the diagnosis of tegumentary leishmaniasis using human serum and urine samples: A preliminary studyRaquel S B Câmara, Dóris M Abrão, Daniela P Lage, et al.
Acta Tropica|March 20, 2022
A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantumAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Vaccines|June 13, 2020
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral LeishmaniasisDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Parasitology Research|September 28, 2023
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasisMarcelo M Jesus, Daniela P Lage, Danniele L Vale, et al.
Vaccines|July 27, 2022
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against <i>Leishmania infantum</i> InfectionDaniela P Lage, Danniele L Vale, Flávia P Linhares, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral LeishmaniasisMarcelo M Jesus, Daniela P Lage, Breno L Pimenta, et al.
Molecular Immunology|February 2, 2023
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasisDaniela P Lage, Amanda S Machado, Camila S Freitas, et al.
Cytokine|March 26, 2022
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infectionDaniela P Lage, Amanda S Machado, Danniele L Vale, et al.
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Acta Bio-Medica : Atenei Parmensis|January 19, 2019
An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendationsVincenzo De Sanctis, Ashraf T Soliman, Duran Canatan, et al.
Pageof 68